Home › Markets › Health Care › RNXT

RenovoRx Inc. (RNXT)

RNXT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$1.15
-8.00% on the day
Market cap
$51.9M
Micro cap
Revenue · 2025
$1.1M
+2511.6% on 2024
Net income · 2025
-$11.2M
-994.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerRNXT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2021
SEC CIK0001574094
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.1M
Net income-$11.2M
Operating income-$12.5M
Net margin-994.5%
Operating margin-1114.0%
Revenue growth+2511.6%
Cash$7.0M
Total assets$8.1M
P/E (computed)Net income was not positive
P/S (computed)46.2×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-04-27
Latest annual report10-K/A2026-05-15
Latest quarterly / interim10-Q2026-08-13
Latest current report8-K2026-08-20
Latest proxyDEF 14A2026-04-30

Source: SEC EDGAR submissions feed, 289 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ATHEAlterity Therapeutics Limited$2.85-2.73%$51.9M
HYPDHyperion DeFi Inc.$3.36-3.17%$51.9M
MREOMereo BioPharma Group plc$0.3200+1.52%$51.1M
IBIOiBio Inc.$0.7818-13.44%$50.3M
ALDXAldeyra Therapeutics Inc.$0.8998-0.66%$54.3M
TLPHTalphera Inc.$1.07-0.93%$55.5M
CLNNClene Inc.$3.39-7.88%$48.2M
HOWLWerewolf Therapeutics Inc.$0.9911+0.95%$48.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier